5.2.1.2	(3Z)-1,3-butadiene-1,1,2,4-tetrol	competitive inhibitor identified by rational design, calculated to be no substrate and not inhibitory to CYP450 and nontoxic in AMES test	224236	
5.2.1.2	(Z)-3-[4-hydroxy-1-(hydroxymethyl)cyclohexyl]-2-propene-1,2-diol	competitive inhibitor identified by rational design, calculated to be no substrate and not inhibitory to CYP450 and nontoxic in AMES test	224237	
5.2.1.2	Dichloroacetate	the sensitivity to the inhibitor varies between enzyme haplotypes. Three nonsynonymous single-nucleotide polymorphisms of GSTz1/MAAI show different activity toward dichloroacetate and certain other xenobiotic haloacids	1160	
5.2.1.2	Dichloroacetic acid	DCA	16175	
5.2.1.2	GSSG	-	330	
5.2.1.2	iodoacetate	-	93	
5.2.1.2	maleylacetone	inhibits isomerization of 6-oxo-2(E),4(Z)-heptanedienoic acid into 6-oxo-2(Z),4(E)-heptanedienoic acid, and the reverse reaction	4539	
5.2.1.2	N-Hexylmaleamic acid	noncompetitive towards GSH and maleylacetone	94313	
5.2.1.2	NaBH4	inhibition in absence of substrate, increases activity in presence of substrate and GSH	616	
5.2.1.2	NEM	biphasic kinetics	89	
5.2.1.2	NEM	-	89	
5.2.1.2	S-Glutathioyl-N-hexylmaleamate	competitive towards GSH, uncompetitive towards maleylacetone	103624	
5.2.1.2	S-Methylglutathione	-	3363